Spring Pharmaceutical (CYIG) 10-K 30 Jun 14 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Mar. 31, 2014	Jun. 16, 2014	Sep. 30, 2013
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Mar-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'CYIG	'	'
Entity Common Stock, Shares Outstanding	'	29,679,690	'
Entity Registrant Name	'China YCT International Group, Inc.	'	'
Entity Central Index Key	'0000847464	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$4,404,664

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEET (USD $)	Mar. 31, 2014	Mar. 31, 2013
Current assets:	'	'
Cash and cash equivalent	$18,624,644	$29,924,188
Accounts receivable	42,049	135,237
Prepaid lease - short term	359,738	20,972
Inventory	1,592,703	1,296,550
Total current assets	20,619,134	31,376,947
Prepaid lease - long term	1,197,768	0
Development cost of acer truncatum bunge planting	15,333,951	0
Plant, property, and equipment, net	13,384,995	9,409,916
Construction in progress	0	220,874
Intangible assets, net	16,684,032	17,656,561
Total assets	67,219,880	58,664,298
Current liabilities:	'	'
Tax payable	816,579	886,706
Other payable	29,552	366,817
Total current liabilities	846,131	1,253,523
Total liabilities	846,131	1,253,523
Stockholders’ Equity	'	'
Preferred stock, par value $500.00 per share; 45 shares authorized and issued at March 31, 2014 and 2013, respectively	22,500	22,500
Common stock, par value $0.001 per share; 500,000,000 and 100,000,000 shares authorized, 29,663,023 shares issued and outstanding at March 31, 2014 and 2013, respectively	29,663	29,663
Additional paid-in capital	4,180,095	4,180,095
Statutory reserve	1,828,504	956,633
Retained earnings	55,676,059	48,426,955
Accumulated other comprehensive income	4,636,928	3,794,929
Total stockholders’ equity	66,373,749	57,410,775
Total liabilities and stockholders’ equity	$67,219,880	$58,664,298

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Preferred stock, par value (in dollars per share)	$500	$500
Preferred stock, shares authorized	45	45
Preferred stock, shares issued	45	45
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	500,000,000	100,000,000
Common stock, shares issued	29,663,023	29,663,023
Common stock, shares outstanding	29,663,023	29,663,023

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Sales Revenue	$34,062,632	$33,102,883
Cost of Goods Sold	16,134,479	16,177,786
Gross Profit	17,928,153	16,925,097
Selling Expenses	2,898,160	2,869,188
G&A Expense	3,077,177	3,116,425
R&D Expenses	1,234,393	1,756,053
Total expense	7,209,730	7,741,666
Income from operation	10,718,423	9,183,431
Interest income (Expense)	79,364	105,722
Unrealized gain on derivative	0	8,297,884
Profit before tax	10,797,787	17,587,037
Income tax	2,676,813	2,326,031
Net income	8,120,974	15,261,006
Other comprehensive income	'	'
Foreign currency translation adjustment	841,999	453,773
Comprehensive income	$8,962,973	$15,714,779
Basic and diluted income per common share	'	'
Basic and Diluted (in dollars per shares)	$0.27	$0.28
Weighted average number of common shares outstanding	'	'
Basic and Diluted (in shares)	29,663,023	55,217,197

CONSOLIDATED_STATEMENT_OF_STOC

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Preferred Stock Series A	Common shares	Additional paid-in capital	Statutory Reserve	Accumulated OCI	Retained Earnings
Balance at Mar. 31, 2012	$41,690,997	$22,500	$73,868	$36,879,555	$956,633	$3,341,156	$417,285
Beginning Balance (in shares) at Mar. 31, 2012	'	45	73,868,110	'	'	'	'
Issuance of common shares to independent directors	5,000	'	50	4,950	'	'	'
Issuance of common shares to independent directors (in shares)	'	'	50,000	'	'	'	'
Cancellation of issued stock for return of patent	0	'	-44,255	-32,704,410	'	'	32,748,665
Cancellation of issued stock for return of patent (in shares)	'	'	-44,255,087	'	'	'	'
Net income for the year	15,261,006	'	'	'	'	'	15,261,005
Foreign currency translation adjustment	453,773	'	'	'	'	453,772	'
Balance at Mar. 31, 2013	57,410,775	22,500	29,663	4,180,095	956,633	3,794,929	48,426,955
Ending Balance (in shares) at Mar. 31, 2013	'	45	29,663,023	'	'	'	'
Issuance of common shares to independent directors	'	'	'	'	'	'	'
Net income for the year	8,120,974	'	'	'	'	'	8,120,974
Statutory reserve	0	'	'	'	871,871	'	-871,871
Other Comprehensive income, net of tax	0	'	'	'	'	'	'
Foreign currency translation adjustment	841,999	'	'	'	'	841,999	'
Balance at Mar. 31, 2014	$66,373,749	$22,500	$29,663	$4,180,095	$1,828,504	$4,636,928	$55,676,059
Ending Balance (in shares) at Mar. 31, 2014	'	45	29,663,023	'	'	'	'

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows From Operating Activities:	'	'
Net income	$8,120,974	$15,261,006
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	1,966,140	1,658,245
Issue of common shares as compensation	0	5,000
Common stock cancellation pursuant to the Termination Agreement	0	-2,765,993
Unrealized gain on derivative	0	-5,531,892
Changes in operating assets and liabilities:	'	'
Inventory	-296,153	681,940
Prepaid land lease	-1,541,479	0
Accounts receivable	93,189	-19,300
Accounts payable	0	73,826
Taxes payable	-70,127	-131,837
Accrued expenses and other payables	-337,266	46,726
Net cash provided by (used in) operating activities	7,935,278	9,277,721
Cash flows from investing activities:	'	'
Addition to plant and equipment	-4,366,208	-92,728
Development cost of acer truncatum bunge planting	-15,333,951	0
Reduction of construction in progress	220,874	0
Prepayment/(deposit) to Jining Tianruitong for purchase of patents	0	-1,754,694
Net cash provided by (used in) investing activities	-19,479,285	-1,847,422
Effect of exchange rate changes on cash and cash equivalents	244,463	347,649
Net increase (decrease) in cash and cash equivalents	-11,299,544	7,777,948
Cash and cash equivalents at beginning of period	29,924,188	22,146,240
Cash and cash equivalents at ending of period	18,624,644	29,924,188
Cash paid during the periods for:	'	'
Interest	453	105,722
Income taxes	2,899,997	2,457,868
Non-cash financing activities:	'	'
Stock issued for services	'	50,000
Stock cancelled for return of patent	'	$44,255,087

ORGANIZATION_AND_PRINCIPAL_ACT

ORGANIZATION AND PRINCIPAL ACTIVITIES	12 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Operations	'
	NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES
	China YCT International Group, Inc. (“China YCT”) was incorporated in the State of Florida, in the United States of America (the “USA”) in January 1989, and reincorporated in the State of Delaware on April 4, 2007.   China YCT, through its 100% owned subsidiary Landway Nano Bio-Tech, Inc. (“Landway Nano”), incorporated in Delaware, owns 100% of Shandong Spring Pharmaceutical Co., Ltd. (“Shandong Spring”), incorporated in the People’s Republic of China (“PRC”). China YCT International Group, Inc. and its subsidiaries are collectively referred to as the “Company”. Shandong Spring is engaged in the business of developing, manufacturing, and selling its own medicine made primarily from gingko extract, research and development of the new food, healthcare and medicine product based on the acer truncatum bunge, now actively developing the acer truncatum bunge planting bases, and distributing health care supplement products manufactured by another company in the PRC.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of presentation
	The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
	Principles of consolidation
	The consolidated financial statements include the financial statements of China YCT, Landway Nano and its wholly owned subsidiary, Shandong Spring.  All inter-company transactions and balances are eliminated in consolidation.
	Use of estimates
	The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. Significant accounting estimates reflected in the Company’s consolidated financial statements include: the valuation of inventory, the estimated useful lives and impairment of property, equipment, and intangible assets.
	Cash and cash equivalents
	For the purposes of the statement of cash flow, the Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
	Accounts receivable
	The Company recognizes as accounts receivable any products shipped where payments have not been rendered. As of March 31, 2014 and 2013, the Company considered all its accounts receivable to be collectable and no provision for doubtful accounts had been made in the consolidated financial statements.
	Inventory
	Inventory is primarily composed of raw materials and packing materials for manufacturing, work in process, and finished goods. Inventories are valued at the lower of cost or market with cost determined on a weighted average basis. Management compares the cost of inventory with the market value and an allowance is made for writing down the inventory to its market value, if lower than cost.
	Property and equipment
	Property and equipment are stated at cost. The cost of an asset comprises its purchase price and any directly attributable costs of bringing the asset to its present working condition and locations for its intended use. Leasehold improvements are stated at cost and amortized over the shorter of the useful life of the assets or the length of the lease in accordance to ASC 840-10-35-6. Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	Buildings	30-35 years
	Machinery, equipment and automobiles	7-15 years
	Furniture and fixtures	7-10 years
	Leasehold improvements	30 years
	Expenditures for maintenance and repairs are charged to expense as incurred. Additions, renewals and betterments are capitalized.
	Intangible Assets
		(i)	Land Use Rights:
	All land in the PRC is owned by the government and cannot be sold to any individual or company.  However, the government may grant a “land use right” for occupying, developing and using land. The Company records land use rights obtained as intangible assets at cost, which is amortized evenly over the grant period of 50 years.
		(ii)	Patents:
	In March 2010, the Company purchased one patent from Shandong YCT Corp.  The patent is the Company’s exclusive right to use an aglycone type and purification method of biotransformation in the gingko product manufacturing process for a period of 20 years from the patent application date.  The patent was recorded at cost when purchased, and is being amortized over the shorter of its remaining legal life, 16.5 years, or its useful life, on a straight-line basis.
	In October 2011, two patents were transferred to the Company based on a purchase agreement signed with Jining Tianruitong Technology development Company, Limited on October 26, 2010; which are “Treatment to ischemic encephalopathy and its preparation method” (ZL200510045001.9) and “Chinese herbal medicine compound to treat renal insufficiency and its preparation” (ZL200710013301.8). The patents were recorded at cost when purchased, and are being amortized over the shorter of the remaining legal lives, 13.75 years and 14.95 years, respectively; or their useful lives, on a straight-line basis.
	Development costs of acer truncatum bunge planting
	The Company has started development of the acer truncatum bunge planting bases and completed planting of 2,200Mu (1Mu is equal to approximately 666.67 square meters) as of the year ended March 31, 2014. The agricultural product (e.g., seeds, oil extract, etc.) derived from the planting is intended to be the supply for an integrated usage including edible oil, protein, medicine and health care, tannin extract, industrial chemicals, nectar source, nervonic acid, and specialty lumber, as well as for landscaping and conservation of soil and water.
	The Company accounts for the development costs of the planting in accordance to ASC Codification 905. Pursuant to ASC 905-360-25-3, limited-life land development costs and direct and indirect development costs of orchards, groves, vineyards, and intermediate-life plants shall be capitalized during the development period. Pursuant to ASC 905-360-35-7, costs capitalized during the development period under paragraph 905-360-25-3 shall be depreciated over the estimated useful life of the land development or that of the tree, vine, or plant. The planting is currently in the development stage with production expected in 2015; therefore, no depreciation expenses were recognized as of March 31, 2014.
	Revenue recognition
	The Company’s revenue recognition policies are in compliance with Staff Accounting Bulletin (“SAB”) 104, included in the Codification as ASC 605, Revenue Recognition. Sales revenue is recognized on the date of shipment to customers when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist, and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are recorded as customer deposits.
	Unearned revenue
	Revenue from the sale of goods or services is recognized at the time that goods are delivered or services are rendered. Receipts in advance for goods to be delivered or services to be rendered in a subsequent period are carried forward as unearned revenue.
	Impairment of long-lived assets
	The Company reviews and evaluates the net carrying value of its long-lived assets at least annually, or upon the occurrence of other events or changes in circumstances that indicate that the related carrying amounts may not be recoverable. Per ASC 360-10-35-21, a long-lived asset (asset group) shall be tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Per ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of the long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group).
	Income taxes
	The Company accounts for income tax under the asset and liability method as stipulated by ASC 740 formerly Statement of Financial Accounting Standards (”SFAS”) No. 109, “ Accounting for Income Taxes”, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns.  Deferred Income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities.  Valuation allowances are established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized. The Company didn’t recognize any deferred tax amount at March 31, 2014 and 2013.
	China YCT International, Inc. is a holding company of Shandong Spring Pharmaceutical Co., Ltd and does not have any operating activities. Although the contract of the acquisition of the US patent was executed by the holding company, in substance, the patent was acquired and is used by the Company’s operating entity in China. For the same reason, the amortization of the patent was a deduction to the Chinese operating entity’s tax liability. Therefore, the Company does not incur any US income tax liabilities.
	Value-added tax
	Sales revenue represents the invoiced value of goods, net of a Value-Added Tax (“VAT”). All of the Company’s products that are sold in the PRC are subject to a Chinese value-added tax at a rate of 17% of the gross sales price. This VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing their finished product.
	The Company recorded net VAT payable in the amount of $205,101 and $349,994 as of March 31, 2014 and 2013, respectively.
	Research and development
	Research and development costs are related primarily to the Company’s development of its intellectual property. Research and development costs are expensed as incurred. The costs of material and equipment that are acquired or constructed for research and development activities and have alternative future uses are classified as plant and equipment and depreciated over their estimated useful lives.
	The research and development expense for the years ended March 31, 2014 and 2013 was $1,234,393 and $1,756,053, respectively.
	Advertising costs
	Advertising costs for newspaper and television are expensed as incurred in accordance to the ASC 720-35 “Advertising Costs”. Pursuant to ASC 720-35-25-5, costs of communication advertising are not incurred until the item or service has been received and shall not be reported as expenses before the item or service has been received, except as discussed in paragraph 340-20-25-2.
	Advertising costs for newspaper and television are expensed as incurred.  The Company incurred advertising costs of $321,669 and $759,866 for the years ended March 31, 2014 and 2013, respectively.
	Mailing and handling costs
	The Company accounts for mailing and handling fees in accordance with the FASB Accounting Standards Codification (“ASC”) 605-45 (Emerging Issues Task Force (EITF) Issue No. 00-10, Accounting for Shipping and Handling Fees and Costs). The Company includes shipping and handling fees billed to customers in net revenues. Amounts incurred by the Company for freight are included in cost of goods sold. For the years ended March 31, 2014 and 2013, the Company incurred $1,272,887 and $1,125,610 mailing and handling costs, respectively.
	Stock Based Compensation
	The Company measures compensation expense for its non-employee stock-based compensation under FASB ASC 718. The fair value of the stock issued is used to measure the transaction, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company’s common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete. The fair value of the equity instrument is charged directly to compensation expense.
	Net income (loss) per share (“EPS”)
	Basic EPS excludes dilution and is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock (convertible preferred stock, forward contracts, warrants to purchase common stock, contingently issuable shares, common stock options and warrants and their equivalents using the treasury stock method) were exercised or converted into common stock. There were nil shares common stock equivalents available for dilution purposes as of March 31, 2014 and 2013.
	Risks and uncertainties
	The Company’s operations are carried out in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environments in the PRC, and by the general state of the PRC’s economy. The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in the North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.
	Fair Value of Financial Instruments
	For certain of the Company’s financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.
	As of March 31, 2014, the Company did not identify any financial instruments that are required to be presented on the balance sheet at fair value other than those whose carrying amounts approximate fair value due to their short maturities.
	Foreign currency translation
	The accounts of the Company’s Chinese subsidiary are maintained in RMB and the accounts of the U.S. parent company are maintained in USD. The accounts of the Chinese subsidiary were translated into USD in accordance with Accounting Standards Codification (“ASC”) Topic 830 “Foreign Currency Matters,” with the RMB as the functional currency for the Chinese subsidiary. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders’ equity is translated at historical rates and statement of income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, “Comprehensive Income.” Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statements of income.
	Translation adjustments resulting from this process amounted to $841,999 and $453,773 for the years ended March 31, 2014 and 2013, respectively.
	The following exchange rates were adopted to translate the amounts from RMB into United States dollars (“USD$”) for the respective periods:
			March 31, 2014		March 31, 2013
Year End RMB Exchange Rate (RMB/USD$)			6.1521		6.2689
Average Period RMB Exchange Rate (RMB/USD$)			6.1551		6.2785
Recent accounting pronouncements
The Company’s management has evaluated all the recently issued accounting pronouncements through the filing date of these consolidated financial statements and does not believe that they will have a material effect on the Company’s consolidated financial position and results of operations.

OPERATING_LEASES

OPERATING LEASES	12 Months Ended
	Mar. 31, 2014
Leases, Operating [Abstract]	'
OPERATING LEASES	'
	NOTE 3 – OPERATING LEASES
	On October 1, 2011, the Company entered into an agreement with Shandong YCT for the lease of one automobile. The lease term is from October 1, 2011 to September 30, 2021. The total lease payment of RMB131,468 (approximately USD21,370) was paid in full at lease signing and amortized over the life of the lease.
	On June 20, 2013, the Company entered into a Farmland Leasing Agreement with Shiqiao Village for the lease of 2,000Mu farmland for the development of the acer truncatum bunge planting bases. The lease term is from July 1, 2013 to June 30, 2043. The lease payment is about RMB1,000(approximately USD 163) per Mu annually and payable for five years of rents in advance. The first lease payment was for the rents of the first five years in the amount of RMB10,000,000 (approximately USD1,625,461), which were made within 15 working days from the signing of the Lease. (See NOTE 15 - FUTURE MINIMUM LEASE PAYMENTS)
	On March 1, 2014, the Company entered into a Farmland Leasing Agreement with Zhongce No.4 Village for the lease of 200Mu farmland to the development of the acer truncatum bunge planting bases. The lease term is from March 1, 2014 to February 28, 2044. The lease payment is RMB1,000,000 (approximately USD 162,541) for each five-year period in advance. The first lease payment was for the rents of the first five years in the amount of RMB1,000,000 (approximately USD162,541), which were made within 10 working days from the signing of the Lease. (See NOTE 14 - FUTURE MINIMUM LEASE PAYMENTS)
	The Company accounts for the lease agreement as an operating lease in accordance to ASC 840-10-25-37, which requires, if land is the sole item of property leased and either the transfer-of-ownership criterion in paragraph 840-10-25-1(a) or the bargain-purchase-option criterion in paragraph 840-10-25-1(b) is met, the lessee shall account for the lease as a capital lease. Otherwise, the lessee shall account for the lease as an operating lease. Per ASC 840-2-25-1, rent shall be charged to expense by lessees over the lease term as it becomes payable.
	The components of prepaid lease were as follows:
	Prepaid leases	As of March 31, 2014
		Short-term		Long-term
	Shiqiao Village – 2000Mu	$	325,092	$	1,056,550
	Zhongce No. 4 Village – 200Mu		32,509		127,328
	Total prepaid land lease		357,601		1,183,878
	Shandong YCT - Automobile		2,137		13,890
	Total prepaid lease	$	359,738	$	1,197,768
	The prepaid lease is amortized based on straight-line method. The lease expenses for the years ended March 31, 2014 and 2013 were $253,275 and $0, respectively.

INVENTORY

INVENTORY	12 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
INVENTORY	'
	NOTE 4 - INVENTORY
	Inventory consists of finished goods, work-in-process, and raw materials. No allowance for inventory was made for the years ended March 31, 2014 and 2013.
	The components of inventories were as follows:
		Year Ended
		March 31, 2014		March 31, 2013
	Raw materials	$	874,455	$	864,956
	Work-in-progress		370,271		391,711
	Finished goods		347,977		39,883
	Total Inventories	$	1,592,703	$	1,296,550

PLANT_PROPERTY_AND_EQUIPMENT_N

PLANT, PROPERTY, AND EQUIPMENT, NET	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
PLANT, PROPERTY AND EQUIPMENT, NET	'
	NOTE 5 – PLANT, PROPERTY, AND EQUIPMENT, NET
	The components of property and equipment were as follows:
		Year Ended
		March 31, 2014		March 31, 2013
	Machinery & Equipment	$	1,461,347	$	638,221
	Furniture & Fixture		192,721		165,203
	Building		12,554,094		10,150,522
	Leasehold Improvements		1,300,369		-
	Subtotal		15,508,531		10,953,946
	Less: Accumulated Depreciation & Amortization		-2,123,536		-1,544,030
	Total plant, property and equipment, net	$	13,384,995	$	9,409,916
	The depreciation and amortization expense for the years ended March 31, 2014 and 2013 was $579,507 and $394,811, respectively.

CONSTRUCTION_IN_PROGRESS

CONSTRUCTION IN PROGRESS	12 Months Ended
	Mar. 31, 2014
Construction In Progress Disclosure [Abstract]	'
CONSTRUCTION IN PROGRESS	'
	NOTE 6 – CONSTRUCTION IN PROGRESS
	Construction in progress represents direct costs of construction or acquisition and design fees incurred for the Company’s new plant and equipment. Capitalization of these costs ceases and the construction in progress is transferred to plant and equipment when substantially all the activities necessary to prepare the assets for their intended use are completed. No depreciation is made until construction is completed and put into use.

MAJOR_CUSTOMER_AND_VENDOR

MAJOR CUSTOMER AND VENDOR	12 Months Ended
	Mar. 31, 2014
Risks and Uncertainties [Abstract]	'
MAJOR CUSTOMER AND VENDOR	'
	NOTE 7 - MAJOR CUSTOMER AND VENDOR
	In the year ended March 31, 2014, the Company mainly sold products to individual retail customers through nine major distributors.
	The Company purchases its products from Shandong Yong Chun Tang (“Shandong YCT”) according to the contract signed on December 26, 2006 between the Company and Shandong YCT. On February 19, 2010, the Company renewed the Purchase and Sale Contract with Shandong YCT for a term of five years ending on February 28, 2015. For the year ended March 31, 2014 and 2013, the purchases from the four major vendors, including Shandong YCT, represent 100% of the Company’s annual total purchase, respectively.

INTANGIBLE_ASSETS_NET

INTANGIBLE ASSETS, NET	12 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
INTANGIBLE ASSETS, NET	'
	NOTE 8 - INTANGIBLE ASSETS, NET
	The intangible assets of the Company consist of land use right and purchased patents.
	Net land use right and purchased patents were as follows:
		Amortization		As of
		Period		March 31, 2014		March 31, 2013
	Land use right		50 years		1,649,517	$	1,618,785
	Less: Accumulated amortization				-248,148		-211,149
	Land use right, net				1,401,369		1,407,636
	Patent 1		16.5 years		7,477,122		7,337,810
	Patent (non-US No. ZL200510045001.9)		13.75 years		10,077,860		9,890,092
	Patent (non-US No. ZL200710013301.8)		14.95 years		1,625,461		1,569,168
	Less: Accumulated amortization				-3,897,780		-2,548,146
	Patents, net			$	15,282,662	$	16,248,925
	The amortization expense of land use right for the years ended March 31, 2014 and 2013 was $36,999 and $33,097, respectively.
	The amortization expense of patent for the years ended March 31, 2014 and 2013 was $1,349,634 and $1,230,336, respectively.

TAX_PAYABLE

TAX PAYABLE	12 Months Ended
	Mar. 31, 2014
Tax Disclosure [Abstract]	'
TAX PAYABLE	'
	NOTE 9 - TAX PAYABLE
	Tax payable at March 31, 2014 and 2013 were as follows:
		As of
		March 31, 2014		March 31, 2013
	Corporate Income Tax	$	567,227	$	508,024
	Value-Added Tax		205,101		349,994
	Other Tax & Fees		44,251		28,688
	Total Tax Payable	$	816,579	$	886,706

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	NOTE 10 - INCOME TAXES
	Shandong Spring Pharmaceutical Co., Ltd is subject to the Enterprise income tax (“EIT”) at a statutory rate of 25%.
	For the years ended March 31, 2014 and 2013, Shandong Spring Pharmaceutical Co., Ltd. recorded income tax provisions of $2,676,813 and $2,326,031, respectively.

UNREALIZED_GAIN_ON_FAIR_VALUE_

UNREALIZED GAIN ON FAIR VALUE OF DERIVATIVE	12 Months Ended
	Mar. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
UNREALIZED GAIN ON FAIR VALUE OF DERIVATIVE	'
	NOTE 11 – UNREALIZED GAIN ON FAIR VALUE OF DERIVATIVE
	Unrealized gain on derivatives reflects a non-cash adjustment for changes in fair value of the Company’s derivative liability associated with a Purchase Agreement, as amended, of an U.S. patent, No. 6,475,531 B1 titled “Safe Botanical Drug for Treatment and Prevention of Influenza and Increasing Immune Function”, between the Company and L.Y. Research Corp., a New Jersey corporation, on February 28, 2011. On October 29, 2012, because the conditions set forth in the Purchase Agreement were not fulfilled, the Company and L.Y. Research Corp. entered into a Termination Agreement to formally terminate the Purchase Agreement, and the Patent was returned to L.Y. Research Corp. and the purchase payment, including the Company’s shares, was returned to the Company. As a result, the derivative obligation and the unrealized gain of $8,297,884 were reversed as of March 31, 2013. There were no unrealized gain on fair value of derivative as of March 31, 2014.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
STOCKHOLDERS' EQUITY	'
	NOTE 12 - STOCKHOLDERS’ EQUITY
	Stock Issued to Independent Directors
	The total amount of the compensation in the form of issuing shares of common stocks to the independent directors was $0 and $5,000 for the years ended March 31, 2014 and 2013, respectively.
	Stock Issued for Acquisition of Patent
	On February 28, 2011, the Company issued 44,254,952 shares of common stock, as a part of the consideration to acquire the U.S. patent, No. 6,475,531 B1 titled “Safe Botanical Drug for Treatment and Prevention of Influenza and Increasing Immune Function”, from L.Y. Research Corp.   The shares of the common stock were valued at the average closing market price on February 28, 2011, aggregating$32,748,665.
	On October 29, 2012, because the conditions set forth in the Purchase Agreement were not fulfilled, the Company and LY Research entered into a Termination Agreement to formally terminate the Purchase Agreement, and the Patent was returned to L.Y. Research Corp. and the purchase payment, including the Company’s shares, was returned to the Company.
	Statutory Reserve
	Subsidiaries incorporated in China are required to make appropriations to reserve funds, based on after-tax net income determined in accordance with generally accepted accounting principles of the People’s Republic of China (“PRC GAAP”).  Effective January 1, 2006, the Company is only required to contribute to one statutory reserve fund at 10% of net income after tax per annum, and any contributions are not to exceed 50% of the respective companies’ registered capital.
	The Company appropriated $871,871 to the statutory reserve based on its net income in 2013. As of March 31, 2014 and 2013, the Company appropriated $1,828,504 and $956,633 to the statutory reserve, respectively.

FUTURE_MINIMUM_LEASE_PAYMENTS

FUTURE MINIMUM LEASE PAYMENTS	12 Months Ended
	Mar. 31, 2014
Operating Leases, Future Minimum Payments Receivable [Abstract]	'
FUTURE MINIMUM LEASE PAYMENTS	'
	NOTE 13 – FUTURE MINIMUM LEASE PAYMENTS
	As of March 31, 2014, future minimum lease payments under the operating lease pursuant to the two Farmland Leasing Agreements were as follows:
	Fiscal year ended March 31,	Shiqiao Village		Zhongce No.4 Village		Total Operating Leases
	2015	$	325,092	$	32,509	$	357,601
	2016		325,092		32,509		357,601
	2017		325,092		32,509		357,601
	2018		325,092		32,509		357,601
	2019		325,092		32,509		357,601
	2020 and thereafter		7,883,488		810,022		8,693,511
	Total minimum lease payments	$	9,508,948	$	972,568	$	10,481,516
	Less: prepaid lease		-1,381,642		-159,837		-1,541,479
	Actual future minimum lease payments		8,127,306		812,731		8,940,037
	The farmland lease payments for the first five years have been made in advance; and therefore, resulted in prepaid lease payments as of March 31, 2014 (refer to Note 3). The actual future minimum lease payments are $8,940,037, after reduction of the prepaid amounts of $1,541,479.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 14 – SUBSEQUENT EVENTS
	There have been no subsequent events as of May 28, 2014.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Basis of presentation	'
	Basis of presentation
	The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Principles of consolidation	'
	Principles of consolidation
	The consolidated financial statements include the financial statements of China YCT, Landway Nano and its wholly owned subsidiary, Shandong Spring.  All inter-company transactions and balances are eliminated in consolidation.
Use of estimates	'
	Use of estimates
	The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. Significant accounting estimates reflected in the Company’s consolidated financial statements include: the valuation of inventory, the estimated useful lives and impairment of property, equipment, and intangible assets.
Cash and cash equivalents	'
	Cash and cash equivalents
	For the purposes of the statement of cash flow, the Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Accounts receivable	'
	Accounts receivable
	The Company recognizes as accounts receivable any products shipped where payments have not been rendered. As of March 31, 2014 and 2013, the Company considered all its accounts receivable to be collectable and no provision for doubtful accounts had been made in the consolidated financial statements.
Inventory	'
	Inventory
	Inventory is primarily composed of raw materials and packing materials for manufacturing, work in process, and finished goods. Inventories are valued at the lower of cost or market with cost determined on a weighted average basis. Management compares the cost of inventory with the market value and an allowance is made for writing down the inventory to its market value, if lower than cost.
Property and equipment	'
	Property and equipment
	Property and equipment are stated at cost. The cost of an asset comprises its purchase price and any directly attributable costs of bringing the asset to its present working condition and locations for its intended use. Leasehold improvements are stated at cost and amortized over the shorter of the useful life of the assets or the length of the lease in accordance to ASC 840-10-35-6. Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	Buildings	30-35 years
	Machinery, equipment and automobiles	7-15 years
	Furniture and fixtures	7-10 years
	Leasehold improvements	30 years
	Expenditures for maintenance and repairs are charged to expense as incurred. Additions, renewals and betterments are capitalized.
Intangible Assets	'
	Intangible Assets
		(i)	Land Use Rights:
	All land in the PRC is owned by the government and cannot be sold to any individual or company.  However, the government may grant a “land use right” for occupying, developing and using land. The Company records land use rights obtained as intangible assets at cost, which is amortized evenly over the grant period of 50 years.
		(ii)	Patents:
	In March 2010, the Company purchased one patent from Shandong YCT Corp.  The patent is the Company’s exclusive right to use an aglycone type and purification method of biotransformation in the gingko product manufacturing process for a period of 20 years from the patent application date.  The patent was recorded at cost when purchased, and is being amortized over the shorter of its remaining legal life, 16.5 years, or its useful life, on a straight-line basis.
	In October 2011, two patents were transferred to the Company based on a purchase agreement signed with Jining Tianruitong Technology development Company, Limited on October 26, 2010; which are “Treatment to ischemic encephalopathy and its preparation method” (ZL200510045001.9) and “Chinese herbal medicine compound to treat renal insufficiency and its preparation” (ZL200710013301.8). The patents were recorded at cost when purchased, and are being amortized over the shorter of the remaining legal lives, 13.75 years and 14.95 years, respectively; or their useful lives, on a straight-line basis.
Development costs of acer truncatum bunge planting	'
	Development costs of acer truncatum bunge planting
	The Company has started development of the acer truncatum bunge planting bases and completed planting of 2,200Mu (1Mu is equal to approximately 666.67 square meters) as of the year ended March 31, 2014. The agricultural product (e.g., seeds, oil extract, etc.) derived from the planting is intended to be the supply for an integrated usage including edible oil, protein, medicine and health care, tannin extract, industrial chemicals, nectar source, nervonic acid, and specialty lumber, as well as for landscaping and conservation of soil and water.
	The Company accounts for the development costs of the planting in accordance to ASC Codification 905. Pursuant to ASC 905-360-25-3, limited-life land development costs and direct and indirect development costs of orchards, groves, vineyards, and intermediate-life plants shall be capitalized during the development period. Pursuant to ASC 905-360-35-7, costs capitalized during the development period under paragraph 905-360-25-3 shall be depreciated over the estimated useful life of the land development or that of the tree, vine, or plant. The planting is currently in the development stage with production expected in 2015; therefore, no depreciation expenses were recognized as of March 31, 2014.
Revenue recognition	'
	Revenue recognition
	The Company’s revenue recognition policies are in compliance with Staff Accounting Bulletin (“SAB”) 104, included in the Codification as ASC 605, Revenue Recognition. Sales revenue is recognized on the date of shipment to customers when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist, and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are recorded as customer deposits.
Unearned revenue	'
	Unearned revenue
	Revenue from the sale of goods or services is recognized at the time that goods are delivered or services are rendered. Receipts in advance for goods to be delivered or services to be rendered in a subsequent period are carried forward as unearned revenue.
Impairment of long-lived assets	'
	Impairment of long-lived assets
	The Company reviews and evaluates the net carrying value of its long-lived assets at least annually, or upon the occurrence of other events or changes in circumstances that indicate that the related carrying amounts may not be recoverable. Per ASC 360-10-35-21, a long-lived asset (asset group) shall be tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Per ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of the long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group).
Income taxes	'
	Income taxes
	The Company accounts for income tax under the asset and liability method as stipulated by ASC 740 formerly Statement of Financial Accounting Standards (”SFAS”) No. 109, “ Accounting for Income Taxes”, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns.  Deferred Income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities.  Valuation allowances are established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized. The Company didn’t recognize any deferred tax amount at March 31, 2014 and 2013.
	China YCT International, Inc. is a holding company of Shandong Spring Pharmaceutical Co., Ltd and does not have any operating activities. Although the contract of the acquisition of the US patent was executed by the holding company, in substance, the patent was acquired and is used by the Company’s operating entity in China. For the same reason, the amortization of the patent was a deduction to the Chinese operating entity’s tax liability. Therefore, the Company does not incur any US income tax liabilities.
Value-added tax	'
	Value-added tax
	Sales revenue represents the invoiced value of goods, net of a Value-Added Tax (“VAT”). All of the Company’s products that are sold in the PRC are subject to a Chinese value-added tax at a rate of 17% of the gross sales price. This VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing their finished product.
	The Company recorded net VAT payable in the amount of $205,101 and $349,994 as of March 31, 2014 and 2013, respectively.
Research and development	'
	Research and development
	Research and development costs are related primarily to the Company’s development of its intellectual property. Research and development costs are expensed as incurred. The costs of material and equipment that are acquired or constructed for research and development activities and have alternative future uses are classified as plant and equipment and depreciated over their estimated useful lives.
	The research and development expense for the years ended March 31, 2014 and 2013 was $1,234,393 and $1,756,053, respectively.
Advertising costs	'
	Advertising costs
	Advertising costs for newspaper and television are expensed as incurred in accordance to the ASC 720-35 “Advertising Costs”. Pursuant to ASC 720-35-25-5, costs of communication advertising are not incurred until the item or service has been received and shall not be reported as expenses before the item or service has been received, except as discussed in paragraph 340-20-25-2.
	Advertising costs for newspaper and television are expensed as incurred.  The Company incurred advertising costs of $321,669 and $759,866 for the years ended March 31, 2014 and 2013, respectively.
Mailing and handling costs	'
	Mailing and handling costs
	The Company accounts for mailing and handling fees in accordance with the FASB Accounting Standards Codification (“ASC”) 605-45 (Emerging Issues Task Force (EITF) Issue No. 00-10, Accounting for Shipping and Handling Fees and Costs). The Company includes shipping and handling fees billed to customers in net revenues. Amounts incurred by the Company for freight are included in cost of goods sold. For the years ended March 31, 2014 and 2013, the Company incurred $1,272,887 and $1,125,610 mailing and handling costs, respectively.
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures compensation expense for its non-employee stock-based compensation under FASB ASC 718. The fair value of the stock issued is used to measure the transaction, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company’s common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete. The fair value of the equity instrument is charged directly to compensation expense.
Net income (loss) per share ("EPS")	'
	Net income (loss) per share (“EPS”)
	Basic EPS excludes dilution and is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock (convertible preferred stock, forward contracts, warrants to purchase common stock, contingently issuable shares, common stock options and warrants and their equivalents using the treasury stock method) were exercised or converted into common stock. There were nil shares common stock equivalents available for dilution purposes as of March 31, 2014 and 2013.
Risks and uncertainties	'
	Risks and uncertainties
	The Company’s operations are carried out in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environments in the PRC, and by the general state of the PRC’s economy. The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in the North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	For certain of the Company’s financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.
	As of March 31, 2014, the Company did not identify any financial instruments that are required to be presented on the balance sheet at fair value other than those whose carrying amounts approximate fair value due to their short maturities.
Foreign currency translation	'
	Foreign currency translation
	The accounts of the Company’s Chinese subsidiary are maintained in RMB and the accounts of the U.S. parent company are maintained in USD. The accounts of the Chinese subsidiary were translated into USD in accordance with Accounting Standards Codification (“ASC”) Topic 830 “Foreign Currency Matters,” with the RMB as the functional currency for the Chinese subsidiary. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders’ equity is translated at historical rates and statement of income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, “Comprehensive Income.” Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statements of income.
	Translation adjustments resulting from this process amounted to $841,999 and $453,773 for the years ended March 31, 2014 and 2013, respectively.
	The following exchange rates were adopted to translate the amounts from RMB into United States dollars (“USD$”) for the respective periods:
			March 31, 2014		March 31, 2013
	Year End RMB Exchange Rate (RMB/USD$)			6.1521		6.2689
	Average Period RMB Exchange Rate (RMB/USD$)			6.1551		6.2785
Recent accounting pronouncements	'
	Recent accounting pronouncements
	The Company’s management has evaluated all the recently issued accounting pronouncements through the filing date of these consolidated financial statements and does not believe that they will have a material effect on the Company’s consolidated financial position and results of operations.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Useful Lives of Property and Equipment	'
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	Buildings	30-35 years
	Machinery, equipment and automobiles	7-15 years
	Furniture and fixtures	7-10 years
	Leasehold improvements	30 years
Exchange Rates Adopted to Translate Amounts from RMB into United States Dollars	'
	The following exchange rates were adopted to translate the amounts from RMB into United States dollars (“USD$”) for the respective periods:
			March 31, 2014		March 31, 2013
	Year End RMB Exchange Rate (RMB/USD$)			6.1521		6.2689
	Average Period RMB Exchange Rate (RMB/USD$)			6.1551		6.2785

OPERATING_LEASES_Tables

OPERATING LEASES (Tables)	12 Months Ended
	Mar. 31, 2014
Leases, Operating [Abstract]	'
Schedule Of Components Of Prepaid Lease	'
	The components of prepaid lease were as follows:
	Prepaid leases	As of March 31, 2014
		Short-term		Long-term
	Shiqiao Village – 2000Mu	$	325,092	$	1,056,550
	Zhongce No. 4 Village – 200Mu		32,509		127,328
	Total prepaid land lease		357,601		1,183,878
	Shandong YCT - Automobile		2,137		13,890
	Total prepaid lease	$	359,738	$	1,197,768

INVENTORY_Tables

INVENTORY (Tables)	12 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Components of Inventories	'
	The components of inventories were as follows:
		Year Ended
		March 31, 2014		March 31, 2013
	Raw materials	$	874,455	$	864,956
	Work-in-progress		370,271		391,711
	Finished goods		347,977		39,883
	Total Inventories	$	1,592,703	$	1,296,550

PLANT_PROPERTY_AND_EQUIPMENT_N1

PLANT, PROPERTY, AND EQUIPMENT, NET (Tables)	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Components of Property and Equipment	'
	The components of property and equipment were as follows:
		Year Ended
		March 31, 2014		March 31, 2013
	Machinery & Equipment	$	1,461,347	$	638,221
	Furniture & Fixture		192,721		165,203
	Building		12,554,094		10,150,522
	Leasehold Improvements		1,300,369		-
	Subtotal		15,508,531		10,953,946
	Less: Accumulated Depreciation & Amortization		-2,123,536		-1,544,030
	Total plant, property and equipment, net	$	13,384,995	$	9,409,916

INTANGIBLE_ASSETS_NET_Tables

INTANGIBLE ASSETS, NET (Tables)	12 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Net Land Use Right and Purchased Patent	'
	Net land use right and purchased patents were as follows:
		Amortization		As of
		Period		March 31, 2014		March 31, 2013
	Land use right		50 years		1,649,517	$	1,618,785
	Less: Accumulated amortization				-248,148		-211,149
	Land use right, net				1,401,369		1,407,636
	Patent 1		16.5 years		7,477,122		7,337,810
	Patent (non-US No. ZL200510045001.9)		13.75 years		10,077,860		9,890,092
	Patent (non-US No. ZL200710013301.8)		14.95 years		1,625,461		1,569,168
	Less: Accumulated amortization				-3,897,780		-2,548,146
	Patents, net			$	15,282,662	$	16,248,925

TAX_PAYABLE_Tables

TAX PAYABLE (Tables)	12 Months Ended
	Mar. 31, 2014
Tax Disclosure [Abstract]	'
Tax Payable	'
	Tax payable at March 31, 2014 and 2013 were as follows:
		As of
		March 31, 2014		March 31, 2013
	Corporate Income Tax	$	567,227	$	508,024
	Value-Added Tax		205,101		349,994
	Other Tax & Fees		44,251		28,688
	Total Tax Payable	$	816,579	$	886,706

FUTURE_MINIMUM_LEASE_PAYMENTS_

FUTURE MINIMUM LEASE PAYMENTS (Tables)	12 Months Ended
	Mar. 31, 2014
Operating Leases, Future Minimum Payments Receivable [Abstract]	'
Schedule of Future Minimum Lease Payments For Operating Lease	'
	As of March 31, 2014, future minimum lease payments under the operating lease pursuant to the two Farmland Leasing Agreements were as follows:
	Fiscal year ended March 31,	Shiqiao Village		Zhongce No.4 Village		Total Operating Leases
	2015	$	325,092	$	32,509	$	357,601
	2016		325,092		32,509		357,601
	2017		325,092		32,509		357,601
	2018		325,092		32,509		357,601
	2019		325,092		32,509		357,601
	2020 and thereafter		7,883,488		810,022		8,693,511
	Total minimum lease payments	$	9,508,948	$	972,568	$	10,481,516
	Less: prepaid lease		-1,381,642		-159,837		-1,541,479
	Actual future minimum lease payments		8,127,306		812,731		8,940,037

ORGANIZATION_AND_PRINCIPAL_ACT1

ORGANIZATION AND PRINCIPAL ACTIVITIES - Additional Information (Detail)	12 Months Ended
	Mar. 31, 2014
Landway Nano Bio-Tech, Inc.	'
Organization and Principal Activities [Line Items]	'
Percentage Of Ownership In Subsidiaries	100.00%
Shandong Spring Pharmaceutical Co., Ltd.	'
Organization and Principal Activities [Line Items]	'
Percentage Of Ownership In Subsidiaries	100.00%

Useful_Lives_of_Property_and_E

Useful Lives of Property and Equipment (Detail)	12 Months Ended
	Mar. 31, 2014
Buildings | Minimum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'30 years
Buildings | Maximum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'35 years
Machinery, equipment and automobiles | Minimum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'7 years
Machinery, equipment and automobiles | Maximum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'15 years
Furniture and fixtures | Minimum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'7 years
Furniture and fixtures | Maximum	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'10 years
Leasehold Improvements [Member]	'
Property, Plant and Equipment [Line Items]	'
Useful lives of property and equipment	'30 years

Exchange_Rates_Adopted_to_Tran

Exchange Rates Adopted to Translate Amounts from RMB into United States Dollars (Detail)	Mar. 31, 2014	Mar. 31, 2013
Foreign Currency Exchange Rate [Line Items]	'	'
Year End RMB Exchange Rate (RMB/USD$)	6.1521	6.2689
Average Period RMB Exchange Rate (RMB/USD$)	6.1551	6.2785

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Accounting Policies [Line Items]	'	'
Value-added tax rate	17.00%	'
Net VAT payable	$205,101	$349,994
Research and development expense	1,234,393	1,756,053
Advertising costs	321,669	759,866
Mailing and handling costs	1,272,887	1,125,610
Foreign currency transaction and translation adjustment	$841,999	$453,773
Patent 1	'	'
Accounting Policies [Line Items]	'	'
Useful life of intangible assets	'16 years 6 months	'
Patent 1 | Shandong YCT	'	'
Accounting Policies [Line Items]	'	'
Useful life of intangible assets	'20 years	'
Patents (non-US No. ZL200510045001.9)	'	'
Accounting Policies [Line Items]	'	'
Useful life of intangible assets	'13 years 9 months	'
Patents (non-US No. ZL200710013301.8)	'	'
Accounting Policies [Line Items]	'	'
Useful life of intangible assets	'14 years 11 months 12 days	'
Land use rights	'	'
Accounting Policies [Line Items]	'	'
Useful life of intangible assets	'50 years	'

OPERATING_LEASES_Detail

OPERATING LEASES (Detail) (USD $)	Mar. 31, 2014
Short-term	$359,738
Long-term	1,197,768
Land [Member]	'
Short-term	357,601
Long-term	1,183,878
Shiqiao Village [Member] | Land [Member]	'
Short-term	325,092
Long-term	1,056,550
Zhongce Village [Member] | Land [Member]	'
Short-term	32,509
Long-term	127,328
Shandong YCT [Member] | Automobile [Member]	'
Short-term	2,137
Long-term	$13,890

OPERATING_LEASES_Additional_In

OPERATING LEASES - Additional Information (Detail)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
	USD ($)	CNY	USD ($)	Farmland Leasing Agreement [Member]	Farmland Leasing Agreement [Member]	Farmland Leasing Agreement [Member]	Farmland Leasing Agreement [Member]
				Shiqiao Village [Member]	Shiqiao Village [Member]	Zhongce Village [Member]	Zhongce Village [Member]
				USD ($)	CNY	USD ($)	CNY
Payments for Leasing Costs	$21,370	131,468	'	'	'	'	'
Annual Operating Leases Rent Expense Minimum Rentals per Mu	'	'	'	163	1,000	162,541	1,000,000
Operating Leases, Rent Expense	$253,275	'	$0	$1,625,461	10,000,000	$162,541	1,000,000
Lease Payment Date of First Required Payment	'	'	'	'15 days	'15 days	'10 days	'10 days

Components_of_Inventories_Deta

Components of Inventories (Detail) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Inventory Disclosure [Line Items]	'	'
Raw materials	$874,455	$864,956
Work-in-progress	370,271	391,711
Finished goods	347,977	39,883
Total Inventories	$1,592,703	$1,296,550

Components_of_Property_and_Equ

Components of Property and Equipment (Detail) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Machinery & Equipment	$1,461,347	$638,221
Furniture & Fixture	192,721	165,203
Building	12,554,094	10,150,522
Leasehold Improvements	1,300,369	0
Subtotal	15,508,531	10,953,946
Less: Accumulated Depreciation & Amortization	-2,123,536	-1,544,030
Total plant, property and equipment, net	$13,384,995	$9,409,916

PLANT_PROPERTY_AND_EQUIPMENT_N2

PLANT, PROPERTY, AND EQUIPMENT, NET - Additional Information (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Depreciation expense	$579,507	$394,811

MAJOR_CUSTOMER_AND_VENDOR_Addi

MAJOR CUSTOMER AND VENDOR - Additional Information (Detail)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Concentration Risk [Line Items]	'	'
Number of major vendors	4	4
Percentage of purchases from major suppliers	100.00%	100.00%

Net_Land_Use_Right_and_Purchas

Net Land Use Right and Purchased Patent (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible assets, net	$16,684,032	$17,656,561
Land use rights	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization Period	'50 years	'
Intangible assets, gross	1,649,517	1,618,785
Less: Accumulated amortization	-248,148	-211,149
Intangible assets, net	1,401,369	1,407,636
Patent 1	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization Period	'16 years 6 months	'
Intangible assets, gross	7,477,122	7,337,810
Patents (non-US No. ZL200510045001.9)	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization Period	'13 years 9 months	'
Intangible assets, gross	10,077,860	9,890,092
Patents (non-US No. ZL200710013301.8)	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization Period	'14 years 11 months 12 days	'
Intangible assets, gross	1,625,461	1,569,168
Patents	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Less: Accumulated amortization	-3,897,780	-2,548,146
Intangible assets, net	$15,282,662	$16,248,925

INTANGIBLE_ASSETS_NET_Addition

INTANGIBLE ASSETS, NET - Additional Information (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Land use rights	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization expense	$36,999	$33,097
Patents	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization expense	$1,349,634	$1,230,336

Tax_Payable_Detail

Tax Payable (Detail) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Taxes [Line Items]	'	'
Corporate Income Tax	$567,227	$508,024
Value-Added Tax	205,101	349,994
Other Tax & Fees	44,251	28,688
Total Tax Payable	$816,579	$886,706

INCOME_TAXES_Additional_Inform

INCOME TAXES - Additional Information (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Taxes [Line Items]	'	'
Income tax provisions	$2,676,813	$2,326,031
Shandong Spring Pharmaceutical	'	'
Income Taxes [Line Items]	'	'
Income tax at statutory rate	25.00%	'

UNREALIZED_GAIN_ON_FAIR_VALUE_1

UNREALIZED GAIN ON FAIR VALUE OF DERIVATIVE- Additional Information (Detail) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Fair Value of Financial Instruments [Line Items]	'	'
Unrealized Gain (Loss) on Derivatives	$0	$8,297,884
L.Y. Research Corp [Member]	'	'
Fair Value of Financial Instruments [Line Items]	'	'
Unrealized Gain (Loss) on Derivatives	'	$8,297,884

STOCKHOLDERS_EQUITY_Additional

STOCKHOLDERS' EQUITY - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended	12 Months Ended
	Jan. 01, 2006	Mar. 31, 2013	Mar. 31, 2014	Feb. 28, 2011	Mar. 31, 2014	Mar. 31, 2013
				Patent (U.S. No. 6,475,531 B1)	Independent Directors	Independent Directors
				L.Y. Research Corp [Member]
Class of Stock [Line Items]	'	'	'	'	'	'
Issuance of common shares to independent directors, value	'	'	'	'	$0	$5,000
Statutory reserve fund	10.00%	'	'	'	'	'
Statutory reserve fund	50.00%	'	'	'	'	'
Statutory reserve on its net income	'	871,871	'	'	'	'
Statutory reserve	'	956,633	1,828,504	'	'	'
Stock Issued During Period, Shares, Purchase of Assets	'	'	'	44,254,952	'	'
Stock Issued During Period, Value, Purchase of Assets	'	'	'	$32,748,665	'	'

FUTURE_MINIMUM_LEASE_PAYMENTS_1

FUTURE MINIMUM LEASE PAYMENTS - (Detail) (USD $)	Mar. 31, 2014
Operating Leased Assets [Line Items]	'
2015	$357,601
2016	357,601
2017	357,601
2018	357,601
2019	357,601
2020 and thereafter	8,693,511
Total minimum lease payments	10,481,516
Less: prepaid lease	-1,541,479
Actual future minimum lease payments	8,940,037
Shiqiao Village [Member]	'
Operating Leased Assets [Line Items]	'
2015	325,092
2016	325,092
2017	325,092
2018	325,092
2019	325,092
2020 and thereafter	7,883,488
Total minimum lease payments	9,508,948
Less: prepaid lease	-1,381,642
Actual future minimum lease payments	8,127,306
Zhongce No.4 Village [Member]	'
Operating Leased Assets [Line Items]	'
2015	32,509
2016	32,509
2017	32,509
2018	32,509
2019	32,509
2020 and thereafter	810,022
Total minimum lease payments	972,568
Less: prepaid lease	-159,837
Actual future minimum lease payments	$812,731

FUTURE_MINIMUM_LEASE_PAYMENTS_2

FUTURE MINIMUM LEASE PAYMENTS -Additional Information (Detail) (USD $)	Mar. 31, 2014
Operating Leased Assets [Line Items]	'
Prepaid Amount Of Future Minimum Lease Payment	$8,940,037
Less: prepaid lease	($1,541,479)